GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi India Ltd (NSE:SANOFI) » Definitions » Total Liabilities

Sanofi India (NSE:SANOFI) Total Liabilities : ₹6,996 Mil (As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Sanofi India Total Liabilities?

Sanofi India's Total Liabilities for the quarter that ended in Dec. 2023 was ₹6,996 Mil.

Sanofi India's quarterly Total Liabilities declined from Jun. 2023 (₹7,734.00 Mil) to Sep. 2023 (₹0.00 Mil) but then increased from Sep. 2023 (₹0.00 Mil) to Dec. 2023 (₹6,996.00 Mil).

Sanofi India's annual Total Liabilities declined from Dec. 2021 (₹8,354.00 Mil) to Dec. 2022 (₹7,959.00 Mil) and declined from Dec. 2022 (₹7,959.00 Mil) to Dec. 2023 (₹6,996.00 Mil).


Sanofi India Total Liabilities Historical Data

The historical data trend for Sanofi India's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi India Total Liabilities Chart

Sanofi India Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,021.00 7,995.00 8,354.00 7,959.00 6,996.00

Sanofi India Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,959.00 - 7,734.00 - 6,996.00

Sanofi India Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sanofi India's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6513+(139+37
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+307)
=6,996

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=17148-10152
=6,996

Sanofi India's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6513+(139+37
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+307)
=6,996

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=17148-10152
=6,996

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sanofi India Total Liabilities Related Terms

Thank you for viewing the detailed overview of Sanofi India's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanofi India (NSE:SANOFI) Business Description

Traded in Other Exchanges
Address
Saki Vihar Road, Sanofi House, CTS Number 117-B, L&T Business Park, Powai, Mumbai, MH, IND, 400072
Sanofi India Ltd is a drug manufacturing company that focuses on a range of therapeutic areas, including Diabetes, Cardiology, Consumer Healthcare, Hospital, Central Nervous System, and Anti-Histamines. The company's diabetes presence includes oral anti-diabetic products and insulin. The consumer healthcare area also maintains a nutraceutical portfolio. The company's export markets include Germany, the U.K., Australia, and Russia. The company utilizes strategic partnerships as a component of its growth strategy.

Sanofi India (NSE:SANOFI) Headlines

No Headlines